Pogorelyy, Mikhail V. https://orcid.org/0000-0003-0773-1204
Kirk, Allison M. https://orcid.org/0000-0002-4286-3678
Adhikari, Samir https://orcid.org/0000-0003-0406-2498
Minervina, Anastasia A.
Sundararaman, Balaji https://orcid.org/0000-0001-8559-1660
Vegesana, Kasi
Brice, David C. https://orcid.org/0000-0002-0294-9987
Scott, Zachary B.
,
Wolf, Joshua
Gaur, Aditya
Hoffman, James M.
Mori, Tomi
Tang, Li
Tuomanen, Elaine I.
Hakim, Hana
Hayden, Randall T.
Hijano, Diego R.
Allison, Kim J.
Allen, E. Kaitlynn
Awad, Walid
Bajracharya, Resha
Clark, Brandi L.
Van de Velde, Lee-Ann
Wilson, Taylor L.
Dallas, Ronald H.
Gowen, Ashleigh
Cole, Amanda
Russell-Bell, Jamie
Castellaw, Ashley
Lin, Chun-Yang
McGargill, Maureen A.
Webby, Richard J.
Wu, Gang
Thomas, Paul G. https://orcid.org/0000-0001-7955-0256
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (U01 AI144616)
U.S. Department of Health & Human Services | National Institutes of Health (P01 AI165077)
U.S. Department of Health & Human Services | National Institutes of Health (75N93021C00016)
U.S. Department of Health & Human Services | National Institutes of Health (75N93019C00052)
Blue-sky grant by ALSAC at St. Jude
Article History
Received: 6 December 2024
Accepted: 13 October 2025
First Online: 24 November 2025
Competing interests
: P.G.T. is on the Scientific Advisory Board of Immunoscape and Shennon Bio, has received research support and personal fees from Elevate Bio, and consulted for 10X Genomics, Illumina, Pfizer, Cytoagents, Sanofi, Merck and JNJ. P.G.T., M.V.P., A.M.K. and A.A.M. have patents related to TCR amplification, cloning and/or applications thereof. The other authors declare no competing interests.